Sexual rehabilitation after treatment for prostate cancer

Cancer

Volumn 71, Issue 3 S, 1993, Pages 1024-1030

  Schover, Leslie R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

cancer; prostate; sexual dysfunction; sexual rehabilitation

Indexed keywords

CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CONFERENCE PAPER; HUMAN; MALE; PATIENT COUNSELING; PENIS ERECTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SEXUAL AROUSAL; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUAL FUNCTION;

AGE FACTORS; AGED; GONADORELIN; HUMAN; IMPOTENCE; MALE; MIDDLE AGE; PENILE ERECTION; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY; SEX BEHAVIOR;

EID: 0027460220     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19930201)71:3+<1024::AID-CNCR2820711421>3.0.CO;2-2     Document Type: Article

References (38)

1. Sexual factors and prostatic cancer: results from a case‐control study
2. Review: prostate cancer epidemiology
3. A case‐control study of prostatic cancer in Kyoto, Japan: sexual risk factors
4. Incidence of prostate cancer and marital status
5. The endocrine effects of visual erotic stimuli in normal men
6. Surgery vs. radiation for localized prostate cancer
7. Antegrade approach to radical retropubic prostatectomy in patients with difficult apical dissection
8. Sexual function after radical prostatectomy
9. Sexual function following radical prostatectomy: influence of preservation of neurovascular bundles
10. Pretreatment evaluation of sexual function in patients with adenocarcinoma of the prostate
11. Results of radiotherapy for localised prostatic carcinoma treated at the Prince of Wales Hospital, Sydney
12. Precise localization of the autonomic nerves from the pelvic plexus to the corpora cavernosa: a detailed anatomical study of the adult male pelvis
13. Neuroanatomy of penile erection: its relevance o iatrogenic impotence
14. Morphometric and clinical studies of 68 consecutive radical prostatectomies
15. Role of nerve‐sparing radical prostatectomy for clinical stage B2 prostate cancer
16. Patient selection for, results of, and impact on tumor resection of potency‐sparing radical prostatectomy
17. Potency following radical prostatectomy with wide unilateral excision of the neurovascular bundle
18. Stage C adenocarcinoma of the prostate: analysis of 551 cases treated with external radiation therapy
19. Pre and posttreatment evaluation of sexual function in patients with adenocarcinoma of the prostate
20. Sexual function in prostatic cancer patients treated with radiotherapy, orchiectomy or oestrogens
21. Sexual function disorders after local radiotherapy for carcinoma of the prostate
22. A study of penile circulation before and after radiation in patients with prostate cancer and its effect on impotence
23. The preservation of potency after external beam irradiation for prostate cancer
24. Radiation‐associated impotence: a clinical study of its mechanism
25. Effects of external radiation therapy for cancer of the prostate on the serum concentrations of testosterone, follicle‐stimulating hormone, luteinizing hormone and prolactin
26. Phase III studies to compare goserelin (Zoladex) with orchiectomy and with diethylstilbestrol in treatment of prostatic carcinoma
27. Patients' choice of treatment in state D prostate cancer
28. A multicenter randomized trial comparing the luteinizing hormone‐releasing hormone analogue goserelin acetate alone and with flutamide in the treatment of advanced prostate cancer
29. Sexuality changes in prostate cancer patients receiving antihormonal therapy combining the antiandrogen flutamide with medical (LHRH agonist) or surgical castration
30. Is there a role for pure antiandrogens in the treatment of advanced prostatic cancer?
31. Clinical evaluation of flutamide and estramustine as initial treatment of metastatic carcinoma of prostate
32. Clinical profile of a new non‐steroidal antiandrogen
33. Changes in erectile responsiveness during androgen replacement therapy
34. Patient acceptance of and satisfaction with an external negative pressure device for impotence
35. Intracavernous injection therapy: analysis of results and complication
36. Treatment of impotency caused by cancer therapy: the inflatable penile prosthesis